![]() Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | ![]() Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | ![]() Mirimus Mirimus is a company that specializes in biotech and preclinical CRO solutions based on genetical engineering. | ![]() Amyris Amyris is a biotechnology research company that develops sustainable ingredients for the clean health and beauty markets. | ||
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 2013 | Founding Date 2010 | Founding Date 2003 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations La Frette, FR HQ | Locations Berkeley, US HQ | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Brooklyn, US HQ | Locations Emeryville, US HQ Sao Paulo, BR |
Employees | Employees 1 | Employees 1477% decrease | Employees 20816% increase | Employees 63 | Employees 1,0031% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 174.4 m | Valuation ($) 256.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $11.2m (FY, 2025) | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $269.8m (FY, 2022) |
Net income | Net income N/A | Net income ($148.1m) (FY, 2025) | Net income ($160.1m) (FY, 2025) | Net income N/A | Net income ($543.4m) (FY, 2022) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 2m (about 15 years ago) | Latest funding round $ 34m (about 7 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 159.5m | Total funding raised $ 210m | Total funding raised N/A | Total funding raised $ 551.9m |

Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company
Mirimus is a company that specializes in biotech and preclinical CRO solutions based on genetical engineering.
View company
Amyris is a biotechnology research company that develops sustainable ingredients for the clean health and beauty markets.
View company